Literature DB >> 23454152

Erectile dysfunction precedes other systemic vascular diseases due to incompetent cavernous endothelial cell-cell junctions.

Ji-Kan Ryu1, Hai-Rong Jin, Guo Nan Yin, Mi-Hye Kwon, Kang-Moon Song, Min Ji Choi, Jin-Mi Park, Nando Dulal Das, Ki-Dong Kwon, Dulguun Batbold, Tack Lee, Zhen Li Gao, Kyu-Won Kim, Woo Jean Kim, Jun-Kyu Suh.   

Abstract

PURPOSE: Erectile dysfunction is often a harbinger of cardiovascular disease. We sought to gain mechanistic insight at the cellular and molecular levels into why erectile dysfunction precedes the clinical consequences of cardiovascular disease.
MATERIALS AND METHODS: Diabetes was induced by intraperitoneal streptozotocin injection in 8-week-old C57BL/6J mice. At 8 weeks after diabetes induction, we determined the expression of endothelial cell-cell junction proteins and vascular endothelial permeability in the penis, heart and hind limb by systemic injection of various vascular space markers (350 Da to 2,000 kDa) or by immunohistochemical staining with antibody to oxidized low density lipoprotein. We also investigated the effect of recombinant Ang1 protein on cavernous endothelial permeability.
RESULTS: Alterations in the integrity of the endothelial cell-cell junction, including a decrease in endothelial cell-cell junction proteins and an increase in vascular permeability to fluorescent tracers or oxidized low density lipoprotein, were prominent in the cavernous tissue of diabetic mice. In contrast, no significant changes in endothelial cell-cell junction proteins or vascular permeability were noted in heart or hind limb tissue according to the diabetic condition. Intracavernous injection of Ang1 protein, an anti-permeability factor, significantly decreased cavernous endothelial permeability to oxidized low density lipoprotein by restoring endothelial cell-cell junction proteins in diabetic mice.
CONCLUSIONS: The incompetent cavernous endothelial cell-cell junction in the diabetic condition provides an important clue to why erectile dysfunction is highly prevalent and often precedes other systemic vascular diseases.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ang1; CVD; EC; ED; HUVEC; ICP; LDL; MCEC; NO; PECAM-1; VE; ZO-1; angiopoietin-1; cardiovascular disease; cardiovascular diseases; diabetes mellitus; endothelial cell-cell; erectile dysfunction; human umbilical vein endothelial cell; intracavernous pressure; intracellular junctions; low density lipoprotein; mouse cavernous endothelial cell; nitric oxide; penis; platelet/endothelial cell adhesion molecule-1; vascular endothelial; zonular occludens-1

Mesh:

Substances:

Year:  2013        PMID: 23454152     DOI: 10.1016/j.juro.2013.02.100

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Erectile dysfunction (ED) after ischemic stroke: association between prevalence and site of lesion.

Authors:  Julia Koehn; Carl Crodel; Martina Deutsch; Peter L Kolominsky-Rabas; Katharina M Hösl; Martin Köhrmann; Stefan Schwab; Max J Hilz
Journal:  Clin Auton Res       Date:  2015-09-15       Impact factor: 4.435

Review 2.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

Review 3.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

Review 4.  The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review.

Authors:  Omer A Raheem; Jeannie J Su; Joel R Wilson; Tung-Chin Hsieh
Journal:  Am J Mens Health       Date:  2016-02-04

5.  The pericyte as a cellular regulator of penile erection and a novel therapeutic target for erectile dysfunction.

Authors:  Guo Nan Yin; Nando Dulal Das; Min Ji Choi; Kang-Moon Song; Mi-Hye Kwon; Jiyeon Ock; Anita Limanjaya; Kalyan Ghatak; Woo Jean Kim; Jae Seog Hyun; Gou Young Koh; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

6.  Identification of endothelial progenitor cells in the corpus cavernosum in rats.

Authors:  Jun Sik Lee; In Sang Hwang; Hyun-Suk Lee; Mi Eun Kim; Young-Woo Seo; Kwangsung Park
Journal:  Biomed Res Int       Date:  2014-10-21       Impact factor: 3.411

7.  Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1.

Authors:  Yun Zhang; Wei Huo; Yan Wen; Hai Li
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

8.  Screening and identification of critical biomarkers in erectile dysfunction: evidence from bioinformatic analysis.

Authors:  Jialiang Hui; Ruiyu Liu; Haibo Zhang; Shuhua He; Anyang Wei
Journal:  PeerJ       Date:  2020-02-28       Impact factor: 2.984

9.  Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice.

Authors:  Kang-Moon Song; Woo Jean Kim; Min-Ji Choi; Ki-Dong Kwon; Anita Limanjaya; Kalyan Ghatak; Jiyeon Ock; Guo Nan Yin; Yasufumi Sato; Soon-Sun Hong; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 10.  Traditional chinese medicine to prevent and treat diabetic erectile dysfunction.

Authors:  Yanfei Feng; Tianhao Shi; Yuli Fu; Bodong Lv
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.